title: Will immunoglobulin therapy of autoimmune blistering skin diseases survive the new financial management of inpatients?
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Späth
authors.forename: Thomas
authors.initials: T
authors.lastname: Hunziker
mesh_terms: D001327:Autoimmune Diseases / Q000188:drug therapy / Q000191:economics*; D001768:Blister / Q000188:drug therapy / Q000191:economics*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000191:economics* / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy / Q000191:economics*
chemical_list: D016756:Immunoglobulins, Intravenous